Lena Schultz
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Inflammatory mediators and NSAID effects 8
-
- Receptor Mechanisms and Signaling 2
- DNA Repair Mechanisms 1
- Co-authors
- Anton Simeonov (13 shared papers)Ajit Jadhav (13 shared papers)David J. Maloney (11 shared papers)Theodore R. Holman (8 shared papers)Ganesha Rai (5 shared papers)Victor Kenyon (5 shared papers)Masaaki Sakurai (2 shared papers)Netra Joshi (5 shared papers)
- Journals
- Journal of Medicinal Chemistry (4 papers)Journal of Clinical Oncology (3 papers)PLoS ONE (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)Molecular BioSystems (1 paper)
- Partner nations
- United StatesSwedenUnited Kingdom
In The Last Decade
Lena Schultz
18 papers receiving 632 citations
Peers
Comparison fields: 5 of 64
- Toxicology 45
- Biochemistry 76
- Pharmacology 95
- Molecular Biology 359
- Organic Chemistry 97
Countries citing papers authored by Lena Schultz
This map shows the geographic impact of Lena Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lena Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lena Schultz more than expected).
Fields of papers citing papers by Lena Schultz
This network shows the impact of papers produced by Lena Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lena Schultz. The network helps show where Lena Schultz may publish in the future.
Co-authors
The 25 scholars most cited alongside Lena Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 135 | |
| 2 | 2014 | 89 | |
| 3 | 2009 | 81 | |
| 4 | 2010 | 70 | |
| 5 | 2014 | 67 | |
| 6 | 2011 | 58 | |
| 7 | 2011 | 33 | |
| 8 | 2010 | 31 | |
| 9 | 2014 | 21 | |
| 10 | Discovery of ML355, a Potent and Selective Inhibitor of Human 12-Lipoxygenase | 2014 | 17 |
| 11 | Discovery of ML351, a Potent and Selective Inhibitor of Human 15-Lipoxygenase-1 | 2014 | 12 |
| 12 | 2023 | 8 | |
| 13 | 2020 | 8 | |
| 14 | 2011 | 8 | |
| 15 | 2025 | 3 | |
| 16 | Potent and selective inhibitors of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (HPGD) | 2011 | 2 |
| 17 | Selective Small Molecule Inhibitors of 12-Human Lipoxygenase (12-hLO) | 2011 | 2 |
| 18 | 2022 | 1 |
About Lena Schultz
Lena Schultz is a scholar working on Pharmacology, Molecular Biology, Toxicology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 646 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (8 papers), Bioactive Compounds and Antitumor Agents (4 papers), Estrogen and related hormone effects (3 papers), Receptor Mechanisms and Signaling (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), DNA Repair Mechanisms (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Toxicology (45 citations), Biochemistry (76 citations), Pharmacology (95 citations), Molecular Biology (359 citations) and Organic Chemistry (97 citations). Lena Schultz has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Anton Simeonov, Ajit Jadhav, David J. Maloney, Theodore R. Holman, Ganesha Rai, Victor Kenyon, Masaaki Sakurai, Netra Joshi, Steve Perry and Udo Oppermann. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Clinical Oncology, PLoS ONE, Journal for ImmunoTherapy of Cancer and Molecular BioSystems.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.